That said, even within the survey, testing RET fusions in MTC has been reported by practitioners regularly prescribing molecular genotyping; this might reflect lack of awareness considering that RET fusions in MTC exist in literature only as case reports [32]. This evidence concerns the gene RET and medullary thyroid gland carcinoma.